Agios Pharmaceuticals reported $248K in Loan Capital for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Agios Pharmaceuticals AGIO:US $ 0.25M 0.08M
Alnylam Pharmaceuticals ALNY:US $ 191.59M 0.31M
Amgen AMGN:US $ 31129M 1766M
Arrowhead Research ARWR:US $ 0 0
Astellas Pharma 4503:JP Y 199021M 62M
AstraZeneca AZN:LN 17874M 120M
Bayer BAYN:GR € 37918M 4722M
Biogen BIIB:US $ 7269.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1076.13M 3.02M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 44505M 3831M
Daiichi Sankyo 4568:JP Y 163441M 92M
Eli Lilly And LLY:US $ 16199.6M 387M
GlaxoSmithKline GSK:LN 23047M 378M
Immunogen IMGN:US $ 0M 0M
JAZZ PHA JAZZ:US $ 1853.03M 4.52M
Mirati Therapeutics MRTX:US $ 0M 0M
Moderna Inc MRNA:US $ 138M 28.13M
Novartis NOVN:VX SF 27399M 579M
Novartis NVS:US $ 26491M 908M
Puma Biotechnology PBYI:US $ 76.35M 7.68M
Regeneron Pharmaceuticals REGN:US $ 1978.9M 716.8M
Sarepta Therapeutics SRPT:US $ 1091.11M 98.62M
Seattle Genetics SGEN:US $ 0M 0M
Vertex Pharmaceuticals VRTX:US $ 572.86M 33.81M